Free Preview of Ru-486, Status Report on the U. S. Commercialization Project, Transfer of Antiprogestin Technology to the United States: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Commit
Ru-486, Status Report on the U. S. Commercialization Project, Transfer of Antiprogestin Technology to the United States: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Commit
Earn 48 points and enjoy extra savings with plum+. Learn more
Overview
Appropriate for
Language
English
No. of Pages
60
Publisher:FB&C Ltd
Shipping dimensions: 9" H x 6" W x 1" L
ISBN: 9781334788680
Life stage: null
You May Also Like
Ratings & Reviews
bvseo_sdk, dw_cartridge, 18.2.0, p_sdk_3.2.0
CLOUD, getReviews, 47ms
reviews, product
bvseo-msg: Unsuccessful GET. status = 'ERROR', msg = 'Not Found.'; Unsuccessful GET. status = 'ERROR', msg = 'Not Found.';
Editorial reviews
Author
Others Also Bought
Choose format
PROMOTION DETAILS
*Valid January 13, 2025 - March 2, 2025 at Canadian stores and at indigo.ca with $30.00 or more purchase of eligible in-stock product(s) in a single transaction before taxes, and after discounts. Not valid on previous purchases or in conjunction with other offers.
Ru-486, Status Report on the U. S. Commercialization Project, Transfer of Antiprogestin Technology to the United States: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Commit/en-ca/ru-486-status-report-on-the-u.-s.-commercialization-project-transfer-of-antiprogestin-technology-to-the-united-states-hearing-before-the-subcommittee-on-regulation-business-opportunities-and-technology-of-the-commit/923CF5DA-1CBE-4D9C-91CD-C47486DE3512.html923CF5DA-1CBE-4D9C-91CD-C47486DE3512
Ru-486, Status Report on the U. S. Commercialization Project, Transfer of Antiprogestin Technology to the United States: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Commit
Ru-486, Status Report On The U.s. Commercialization Project, Transfer Of Antiprogestin Technology To The United States: Hearing Before The Subcommittee On Regulation, Business Opportunities, And Technology Of The Commit